Expanding the Sisu Team

Sisu Global Health needs to make a few hires- please spread the word! If you or anyone you know might be interested in any of the following positions, please see our Careers page. If you have any questions, please send an email to jobs@sisuglobalhealth.com. 

Program Manager (Baltimore, MD, USA)

The program manager will be responsible for maintaining the portfolio of projects within Sisu Global Health.  The program manager will determine the personnel and budget needed to achieve the strategic objectives and will be responsible for the prioritizing the allocation of resources to keep project milestones on track. The program manager will hold each project lead accountable to project progress and will be able to reallocate personnel and budget as needed to meet strategic objectives. The position would report directly to CEO. This full-time role will need to take on additional responsibilities depending on experience (e.g. contract management, HR, project management).

Download the full Program Manager job description here.

Production Manager (Baltimore, USA)

The production manager will be responsible to direct the organization's manufacturing and supply chain operations. He or she will develop and implement plans to efficiently utilize materials, labor, and equipment along with ensuring that all parts, assemblies, and final products are produced on schedule and according to established requirements. The production manager will establish processes, policies, and procedures and ensure all changes align with the organization's objectives. He or she will coordinate with quality, and related departments to resolve quality issues through root cause analysis and corrective action.

Download the full Program Manager job description here.

Marketing Manager (Accra, Ghana)

The Sales & Marketing Manager is responsible for all aspects of planning and implementing the West African sales and marketing strategy for Sisu Global Health. Additionally, the Senior Sales & Marketing Manager will help to structure the subsidiary of Sisu Global Health, Sisu Ghana Health, to create the foundation for West African operations. This position reports directly to the Chief Marketing Officer.

Download the full Marketing Manager job description here.

Sales Director (Flexible Location)

We are looking for a high-performing Sales Director to cover East and West Africa regions. The successful candidate will coordinate in-country Marketing managers to engage hospital targets. The Sales Director will also work directly with in-country distributors to meet revenue growth objectives. Sales director duties will include hitting annual targets, building relationships and understanding customer trends.

Download the full Sales Director job description here. 

Katie KirschComment
August Update: Regulatory Clearance, GSBI Fellowship and SL@B

Key Milestone Achieved: Regulatory Approval in Ghana

Exactly one month after we received our regulatory approval in Kenya, we received our regulatory approval in Ghana. These regulatory approvals are a testament to Hemafuse and the hard and diligent work of our team.

With two regulatory approvals achieved, we  now have the opportunity to secure purchase orders in two key markets. Ghana is the launching point for the West African market while Kenya is the launching point for the East African market. Once we secure our next round of funding we will be well positioned to enter these two markets and then scale rapidly!

Winners of $250k Saving Lives at Birth Grant

We are proud to be the an awardee for the Saving Lives at Birth Validation Grant. This is the second stage of a grant we had been awarded 3 years ago and will fund a multi-country evaluation of Hemafuse. We will also hear in the next couple of months if we qualify for additional funds in addition to the $250k award so keep your ears tuned for even better news!

Sisu was one of just 15 submissions selected out of 550 applicants from around the globe for the prestigious grant from the U.S. Agency for International Development (USAID), the Bill & Melinda Gates Foundation, Grand Challenges Canada (funded by the Government of Canada), the Norwegian Agency for Development Cooperation (Norad), the U.K’s Department for International Development (DFID) and the Korea International Cooperation Agency (KOICA). 

Katie KirschComment
CAMTech First Mile Innovation
Carolyn Yarina, Sisu's CEO, pictured at the World Health Assembly this past June. 

Carolyn Yarina, Sisu's CEO, pictured at the World Health Assembly this past June. 

Sisu Global Health recently won the First Mile Innovation Challenge from  the Consortium of Affordable Medical Technologies (CAMTech), GE Sustainable Healthcare Solutions and Massachusetts General Hospital's Global Health program. This competition sought applications from around the world that address health hardships in low and middle income countries. Sisu was the sole winner of a $25,000 grant and access to GE’s five.eight accelerator network. Over 80 projects competed from companies across the world. GE Healthcare also featured Sisu in Geneva at the 2017 World Health Assembly for this award in June. Check out our photo diary featured via CAMTech here

Katie KirschComment
New Office(s)

Sisu is still moving and shaking! More on the former, as Sisu now has a new office in Baltimore. We are now located on 2720 Sisson Street in the Remington neighborhood. We welcome visitors interested to learn more about medical devices in emerging markets, partnership opportunities and those interested in trying our products. 

Our Chief Marketing Officer, Katie Kirsch, is on the African continent for a majority of this year. She will be primarily based in Accra, but has plans to engage markets in Eastern and Southern Africa. She plans to set up direct channels for Hemafuse sales over the coming months. 

Blood Bag Hands
Expanding Our Scope

Sisu continues to expand application of Hemafuse, its first portfolio product, by approaching new clinical sites across the southern hemisphere. 

Hiccups happen.

In the past, we made the assumption that as a small team, we need a laser focus to push forward. This has been ingrained in us from the teachings of a US infrastructure with a clear path to market. The steps may be bureaucratic and long, but they are also consistent, documented, and well understood. Input produces an output. But we don’t work in the US, we work in Africa with a fluid landscape where the incentives are different.

This requires a new multi-approach to kicking off our initial pilot study for Hemafuse. Originally, our laser focus approach involved coordinating with a single clinical site in Sub-Saharan Africa. The partnership seemed to have the capability/titles/clinical experience to get Hemafuse in the hands that want to use it. Finding the hands wasn’t difficult. The trick is also finding clinicians with the time and support to truly scrutinize a medical device’s first time in surgery.

Systematic, research-focused protocols (like it sounds) are a lot of work. Feel free to ask any specialist in academia; their jobs are not easy. And without major incentives for publication, often a tool for career advancement, the cost/benefit of doing a small pilot study is not always available to all of our African partners.

Lucky for us, not all. It was time to seek a second opinion. And we were overwhelmed with the response.

Through several of our Baltimore-based partners, the Gates Foundation network and some cold calls, we discovered that these doctors are calling to do the research. We just needed to present them with the option. The quantity and quality of the responses has been massive; and our confidence in coordinating this study abroad has been restored.  And led to some significant realizations on our approach.

The research support and new leads generated by expanding our geographic scope for this initial pilot has not only enabled our clinical strategy, but begun to anecdotally increase demand. Unlike clinicians and researchers in other contexts, our current partners repeatedly ask questions on supply chain management and how they can build purchase capacity in their institution. Their intent is beyond the initial research study. They are excited by the possibility of such an innovation becoming a valuable tool in their practice, once it’s been proven.

Our original, narrow focus on a single country for smaller studies was a short-sighted assumption around speed through regulatory and first sales.  By looking beyond that single variable, we’ve reminded ourselves that we are building a system and rediscovered our mission: incentivizing stakeholders along the entire value chain. This engagement continues to be scarce as evidenced by our clinician’s entrepreneurial and multi-lateral concerns. Their hospitals, and the distributors that supply them, will eventually be our customers. Their investments in the innovation of Hemafuse at this early stage will influence our B2B relationships well into the future.

Want to hear more about Sisu's mission? Come see CMO, Katie Kirsch, talk at Light City's Health Innovation Conference

Katie Kirsch Comment